Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Actelion Setback Ahead Of J&J Deal Closure

Jun 08 2017

• By Sukaina Virji

3D illustration of Clostridium difficile bacteria. Bacteria which cause pseudomembraneous colitis and are associated with nosocomial antibiotic resistance — Clostridium difficile bacteria in 3D

Related Content

Tetraphase Bets On I.V. Eravacycline Rerun As Antibiotic Market Influx Looms

May 17 2017

Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In

May 23 2017

Pfizer To Take Zinplava Rival Into Phase III For C Diff

Jan 30 2017

Related Companies

Actelion Pharmaceuticals Ltd.

Johnson & Johnson

Tetraphase Pharmaceuticals, Inc.

Additional Topics

Research & Development Companies Infectious Diseases BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window